<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Nature</journal-id>
        <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
        <journal-id journal-id-type="pmc-domain-id">981</journal-id>
        <journal-id journal-id-type="pmc-domain">npgopen</journal-id>
        <journal-title-group>
          <journal-title>Nature</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">0028-0836</issn>
        <issn pub-type="epub">1476-4687</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>Nature Portfolio</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC4170219</article-id>
        <article-id pub-id-type="pmcid-ver">PMC4170219.2</article-id>
        <article-id pub-id-type="pmcaid">4170219</article-id>
        <article-id pub-id-type="pmcaiid">8171191</article-id>
        <article-id pub-id-type="pmid">25079317</article-id>
        <article-id pub-id-type="doi">10.1038/nature13480</article-id>
        <article-id pub-id-type="publisher-id">BFnature13480</article-id>
        <article-version article-version-type="pmc-version">2</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Comprehensive molecular characterization of gastric adenocarcinoma</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <collab>The Cancer Genome Atlas Research Network<contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Bass</surname><given-names initials="AJ">Adam J.</given-names></name><address><email>adam_bass@dfci.harvard.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><on-behalf-of>for the Analysis Working Group: Dana-Farber Cancer Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Thorsson</surname><given-names initials="V">Vesteinn</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shmulevich</surname><given-names initials="I">Ilya</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reynolds</surname><given-names initials="SM">Sheila M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miller</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bernard</surname><given-names initials="B">Brady</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><on-behalf-of>for the Institute for Systems Biology</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hinoue</surname><given-names initials="T">Toshinori</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Laird</surname><given-names initials="PW">Peter W.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Curtis</surname><given-names initials="C">Christina</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shen</surname><given-names initials="H">Hui</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weisenberger</surname><given-names initials="DJ">Daniel J.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><on-behalf-of>for the University of Southern California</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Schultz</surname><given-names initials="N">Nikolaus</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shen</surname><given-names initials="R">Ronglai</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weinhold</surname><given-names initials="N">Nils</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kelsen</surname><given-names initials="DP">David P.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><on-behalf-of>for the Memorial Sloan Kettering Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bowlby</surname><given-names initials="R">Reanne</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chu</surname><given-names initials="A">Andy</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kasaian</surname><given-names initials="K">Katayoon</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mungall</surname><given-names initials="AJ">Andrew J.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Robertson</surname><given-names initials="AG">A. Gordon</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sipahimalani</surname><given-names initials="P">Payal</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><on-behalf-of>for the BC Cancer Agency</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cherniack</surname><given-names initials="A">Andrew</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Getz</surname><given-names initials="G">Gad</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Y">Yingchun</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Noble</surname><given-names initials="MS">Michael S.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pedamallu</surname><given-names initials="C">Chandra</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sougnez</surname><given-names initials="C">Carrie</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Taylor-Weiner</surname><given-names initials="A">Amaro</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><on-behalf-of>for the The Eli &amp; Edythe L. Broad Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Akbani</surname><given-names initials="R">Rehan</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="JS">Ju-Seog</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="W">Wenbin</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mills</surname><given-names initials="GB">Gordon B.</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="D">Da</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="W">Wei</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><on-behalf-of>for the MD Anderson Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Pantazi</surname><given-names initials="A">Angeliki</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Parfenov</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><on-behalf-of>for the Harvard Medical School</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gulley</surname><given-names initials="M">Margaret</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><on-behalf-of>for the University of North Carolina</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Piazuelo</surname><given-names initials="MB">M. Blanca</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schneider</surname><given-names initials="BG">Barbara G.</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><on-behalf-of>for the Vanderbilt University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="J">Jihun</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><on-behalf-of>for the Asan Medical Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Boussioutas</surname><given-names initials="A">Alex</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><on-behalf-of>for the University of Melbourne</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sheth</surname><given-names initials="M">Margi</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Demchok</surname><given-names initials="JA">John A.</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rabkin</surname><given-names initials="CS">Charles S.</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><on-behalf-of>for the National Cancer Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Willis</surname><given-names initials="JE">Joseph E.</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><on-behalf-of>for the Case Western Reserve University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ng</surname><given-names initials="S">Sam</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><on-behalf-of>for the University of California at Santa Cruz</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Garman</surname><given-names initials="K">Katherine</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><on-behalf-of>for the Duke University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Beer</surname><given-names initials="DG">David G.</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><on-behalf-of>for the University of Michigan</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Pennathur</surname><given-names initials="A">Arjun</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><on-behalf-of>for the University of Pittsburgh</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Raphael</surname><given-names initials="BJ">Benjamin J.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="HT">Hsin-Ta</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><on-behalf-of>for the Brown University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Odze</surname><given-names initials="R">Robert</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><on-behalf-of>for the Brigham and Women’s Hospital</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="HK">Hark K.</given-names></name><xref ref-type="aff" rid="Aff27">27</xref></contrib><on-behalf-of>for the National Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bowen</surname><given-names initials="J">Jay</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Leraas</surname><given-names initials="KM">Kristen M.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lichtenberg</surname><given-names initials="TM">Tara M.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weaver</surname><given-names initials="S">Stephanie</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><on-behalf-of>for the Nationwide Children’s Hospital</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>McLellan</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><on-behalf-of>for the Washington University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Wiznerowicz</surname><given-names initials="M">Maciej</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><on-behalf-of>for the Greater Poland Cancer Centre</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sakai</surname><given-names initials="R">Ryo</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><on-behalf-of>for the KU Leuven</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Getz</surname><given-names initials="G">Gad</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sougnez</surname><given-names initials="C">Carrie</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lawrence</surname><given-names initials="MS">Michael S.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cibulskis</surname><given-names initials="K">Kristian</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lichtenstein</surname><given-names initials="L">Lee</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fisher</surname><given-names initials="S">Sheila</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gabriel</surname><given-names initials="SB">Stacey B.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lander</surname><given-names initials="ES">Eric S.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><on-behalf-of>for the Genome Sequencing Center: The Eli &amp; Edythe L. Broad Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ding</surname><given-names initials="L">Li</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Niu</surname><given-names initials="B">Beifang</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><on-behalf-of>for the Washington University in St. Louis</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ally</surname><given-names initials="A">Adrian</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Balasundaram</surname><given-names initials="M">Miruna</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Birol</surname><given-names initials="I">Inanc</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bowlby</surname><given-names initials="R">Reanne</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brooks</surname><given-names initials="D">Denise</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Butterfield</surname><given-names initials="YSN">Yaron S. N.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carlsen</surname><given-names initials="R">Rebecca</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chu</surname><given-names initials="A">Andy</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chu</surname><given-names initials="J">Justin</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chuah</surname><given-names initials="E">Eric</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chun</surname><given-names initials="HJE">Hye-Jung E.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Clarke</surname><given-names initials="A">Amanda</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dhalla</surname><given-names initials="N">Noreen</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guin</surname><given-names initials="R">Ranabir</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Holt</surname><given-names initials="RA">Robert A.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jones</surname><given-names initials="SJM">Steven J. M.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kasaian</surname><given-names initials="K">Katayoon</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="D">Darlene</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="HA">Haiyan A.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lim</surname><given-names initials="E">Emilia</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ma</surname><given-names initials="Y">Yussanne</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marra</surname><given-names initials="MA">Marco A.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mayo</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moore</surname><given-names initials="RA">Richard A.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mungall</surname><given-names initials="AJ">Andrew J.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mungall</surname><given-names initials="KL">Karen L.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ming Nip</surname><given-names initials="K">Ka</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Robertson</surname><given-names initials="AG">A. Gordon</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schein</surname><given-names initials="JE">Jacqueline E.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sipahimalani</surname><given-names initials="P">Payal</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tam</surname><given-names initials="A">Angela</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thiessen</surname><given-names initials="N">Nina</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><on-behalf-of>for the Genome Characterization Centers: BC Cancer Agency</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Beroukhim</surname><given-names initials="R">Rameen</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carter</surname><given-names initials="SL">Scott L.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cherniack</surname><given-names initials="AD">Andrew D.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cho</surname><given-names initials="J">Juok</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cibulskis</surname><given-names initials="K">Kristian</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>DiCara</surname><given-names initials="D">Daniel</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Frazer</surname><given-names initials="S">Scott</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fisher</surname><given-names initials="S">Sheila</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gabriel</surname><given-names initials="SB">Stacey B.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gehlenborg</surname><given-names initials="N">Nils</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Heiman</surname><given-names initials="DI">David I.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jung</surname><given-names initials="J">Joonil</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="J">Jaegil</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lander</surname><given-names initials="ES">Eric S.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lawrence</surname><given-names initials="MS">Michael S.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lichtenstein</surname><given-names initials="L">Lee</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="P">Pei</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meyerson</surname><given-names initials="M">Matthew</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ojesina</surname><given-names initials="AI">Akinyemi I.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sekhar Pedamallu</surname><given-names initials="C">Chandra</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saksena</surname><given-names initials="G">Gordon</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schumacher</surname><given-names initials="SE">Steven E.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sougnez</surname><given-names initials="C">Carrie</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stojanov</surname><given-names initials="P">Petar</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tabak</surname><given-names initials="B">Barbara</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Taylor-Weiner</surname><given-names initials="A">Amaro</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Voet</surname><given-names initials="D">Doug</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names initials="M">Mara</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zack</surname><given-names initials="TI">Travis I.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="H">Hailei</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zou</surname><given-names initials="L">Lihua</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><on-behalf-of>for the The Eli &amp; Edythe L. Broad Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Protopopov</surname><given-names initials="A">Alexei</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Santoso</surname><given-names initials="N">Netty</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Parfenov</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="S">Semin</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="J">Jianhua</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mahadeshwar</surname><given-names initials="HS">Harshad S.</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tang</surname><given-names initials="J">Jiabin</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ren</surname><given-names initials="X">Xiaojia</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Seth</surname><given-names initials="S">Sahil</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="L">Lixing</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="AW">Andrew W.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Song</surname><given-names initials="X">Xingzhi</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pantazi</surname><given-names initials="A">Angeliki</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xi</surname><given-names initials="R">Ruibin</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bristow</surname><given-names initials="CA">Christopher A.</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hadjipanayis</surname><given-names initials="A">Angela</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Seidman</surname><given-names initials="J">Jonathan</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chin</surname><given-names initials="L">Lynda</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="PJ">Peter J.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kucherlapati</surname><given-names initials="R">Raju</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><on-behalf-of>for the Harvard Medical School/Brigham &amp; Women’s Hospital/MD Anderson Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Akbani</surname><given-names initials="R">Rehan</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ling</surname><given-names initials="S">Shiyun</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="W">Wenbin</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rao</surname><given-names initials="A">Arvind</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weinstein</surname><given-names initials="JN">John N.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="SB">Sang-Bae</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="JS">Ju-Seog</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lu</surname><given-names initials="Y">Yiling</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mills</surname><given-names initials="G">Gordon</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><on-behalf-of>for the MD Anderson Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Laird</surname><given-names initials="PW">Peter W.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hinoue</surname><given-names initials="T">Toshinori</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weisenberger</surname><given-names initials="DJ">Daniel J.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bootwalla</surname><given-names initials="MS">Moiz S.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lai</surname><given-names initials="PH">Phillip H.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shen</surname><given-names initials="H">Hui</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Triche Jr</surname><given-names initials="T">Timothy</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Van Den Berg</surname><given-names initials="DJ">David J.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><on-behalf-of>for the University of Southern California Epigenome Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Baylin</surname><given-names initials="SB">Stephen B.</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Herman</surname><given-names initials="JG">James G.</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><on-behalf-of>for the The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Getz</surname><given-names initials="G">Gad</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chin</surname><given-names initials="L">Lynda</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Y">Yingchun</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murray</surname><given-names initials="BA">Bradley A.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Noble</surname><given-names initials="MS">Michael S.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><on-behalf-of>for the Genome Data Analysis Centers: The Eli &amp; Edythe L. Broad Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Arman Askoy</surname><given-names initials="RB">r B.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ciriello</surname><given-names initials="G">Giovanni</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dresdner</surname><given-names initials="G">Gideon</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="J">Jianjiong</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gross</surname><given-names initials="B">Benjamin</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jacobsen</surname><given-names initials="A">Anders</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="W">William</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ramirez</surname><given-names initials="R">Ricardo</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sander</surname><given-names initials="C">Chris</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schultz</surname><given-names initials="N">Nikolaus</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Senbabaoglu</surname><given-names initials="Y">Yasin</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sinha</surname><given-names initials="R">Rileen</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Onur Sumer</surname><given-names initials="S">S.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="Y">Yichao</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weinhold</surname><given-names initials="N">Nils</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><on-behalf-of>for the Memorial Sloan-Kettering Cancer Cente</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Thorsson</surname><given-names initials="V">Vésteinn</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bernard</surname><given-names initials="B">Brady</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Iype</surname><given-names initials="L">Lisa</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kramer</surname><given-names initials="RW">Roger W.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kreisberg</surname><given-names initials="R">Richard</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miller</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reynolds</surname><given-names initials="SM">Sheila M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rovira</surname><given-names initials="H">Hector</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tasman</surname><given-names initials="N">Natalie</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shmulevich</surname><given-names initials="I">Ilya</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><on-behalf-of>for the Institute for Systems Biology</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ng</surname><given-names initials="S">Sam</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Haussler</surname><given-names initials="D">David</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stuart</surname><given-names initials="JM">Josh M.</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><on-behalf-of>for the University of California, Santa Cruz</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Akbani</surname><given-names initials="R">Rehan</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ling</surname><given-names initials="S">Shiyun</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="W">Wenbin</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rao</surname><given-names initials="A">Arvind</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weinstein</surname><given-names initials="JN">John N.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Verhaak</surname><given-names initials="RGW">Roeland G. W.</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mills</surname><given-names initials="GB">Gordon B.</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><on-behalf-of>for the MD Anderson Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Leiserson</surname><given-names initials="MDM">Mark D. M.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Raphael</surname><given-names initials="BJ">Benjamin J.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="HT">Hsin-Ta</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><on-behalf-of>for the Brown University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Taylor</surname><given-names initials="BS">Barry S.</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><on-behalf-of>for the University of California San Francisco</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Black</surname><given-names initials="AD">Aaron D.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bowen</surname><given-names initials="J">Jay</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ann Carney</surname><given-names initials="J">Julie</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gastier-Foster</surname><given-names initials="JM">Julie M.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Helsel</surname><given-names initials="C">Carmen</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Leraas</surname><given-names initials="KM">Kristen M.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lichtenberg</surname><given-names initials="TM">Tara M.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McAllister</surname><given-names initials="C">Cynthia</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ramirez</surname><given-names initials="NC">Nilsa C.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tabler</surname><given-names initials="TR">Teresa R.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wise</surname><given-names initials="L">Lisa</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zmuda</surname><given-names initials="E">Erik</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><on-behalf-of>for the Biospecimen Core Resource: The Research Institute at Nationwide Children’s Hospital</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Penny</surname><given-names initials="R">Robert</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Crain</surname><given-names initials="D">Daniel</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gardner</surname><given-names initials="J">Johanna</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lau</surname><given-names initials="K">Kevin</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Curely</surname><given-names initials="E">Erin</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mallery</surname><given-names initials="D">David</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morris</surname><given-names initials="S">Scott</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Paulauskis</surname><given-names initials="J">Joseph</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shelton</surname><given-names initials="T">Troy</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shelton</surname><given-names initials="C">Candace</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sherman</surname><given-names initials="M">Mark</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><on-behalf-of>for the International Genomics Consortium</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Benz</surname><given-names initials="C">Christopher</given-names></name><xref ref-type="aff" rid="Aff37">37</xref></contrib><on-behalf-of>for the Tissue Source Sites: Buck Institute for Research on Aging</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="JH">Jae-Hyuk</given-names></name><xref ref-type="aff" rid="Aff38">38</xref></contrib><on-behalf-of>for the Chonnam National University Medical School</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Fedosenko</surname><given-names initials="K">Konstantin</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Manikhas</surname><given-names initials="G">Georgy</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><on-behalf-of>for the City Clinical Oncology Dispensary</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Potapova</surname><given-names initials="O">Olga</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Voronina</surname><given-names initials="O">Olga</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Belyaev</surname><given-names initials="D">Dmitry</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dolzhansky</surname><given-names initials="O">Oleg</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><on-behalf-of>for the Cureline</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kimryn Rathmell</surname><given-names initials="W">W.</given-names></name><xref ref-type="aff" rid="Aff41">41</xref></contrib><on-behalf-of>for the UNC Lineberger Comprehensive Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Brzezinski</surname><given-names initials="J">Jakub</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ibbs</surname><given-names initials="M">Matthew</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Korski</surname><given-names initials="K">Konstanty</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kycler</surname><given-names initials="W">Witold</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Łaźniak</surname><given-names initials="R">Radoslaw</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Leporowska</surname><given-names initials="E">Ewa</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mackiewicz</surname><given-names initials="A">Andrzej</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murawa</surname><given-names initials="D">Dawid</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murawa</surname><given-names initials="P">Pawel</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Spychała</surname><given-names initials="A">Arkadiusz</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Suchorska</surname><given-names initials="WM">Wiktoria M.</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tatka</surname><given-names initials="H">Honorata</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Teresiak</surname><given-names initials="M">Marek</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wiznerowicz</surname><given-names initials="M">Maciej</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><on-behalf-of>for the Greater Poland Cancer Centre</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Abdel-Misih</surname><given-names initials="R">Raafat</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bennett</surname><given-names initials="J">Joseph</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brown</surname><given-names initials="J">Jennifer</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Iacocca</surname><given-names initials="M">Mary</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rabeno</surname><given-names initials="B">Brenda</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><on-behalf-of>for the Helen F. Graham Cancer Center &amp; Research Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kwon</surname><given-names initials="SY">Sun-Young</given-names></name><xref ref-type="aff" rid="Aff43">43</xref></contrib><on-behalf-of>for the Keimyung University School of Medicine</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Penny</surname><given-names initials="R">Robert</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gardner</surname><given-names initials="J">Johanna</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kemkes</surname><given-names initials="A">Ariane</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mallery</surname><given-names initials="D">David</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morris</surname><given-names initials="S">Scott</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shelton</surname><given-names initials="T">Troy</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shelton</surname><given-names initials="C">Candace</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Curley</surname><given-names initials="E">Erin</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><on-behalf-of>for the International Genomics Consortium</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Alexopoulou</surname><given-names initials="I">Iakovina</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Engel</surname><given-names initials="J">Jay</given-names></name><xref ref-type="aff" rid="Aff45">45</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bartlett</surname><given-names initials="J">John</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Albert</surname><given-names initials="M">Monique</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><on-behalf-of>for the Ontario Tumour Bank</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="DY">Do-Youn</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><on-behalf-of>for the Pusan National University Hospital</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Dhir</surname><given-names initials="R">Rajiv</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Luketich</surname><given-names initials="J">James</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Landreneau</surname><given-names initials="R">Rodney</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><on-behalf-of>for the University of Pittsburgh School of Medicine</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Janjigian</surname><given-names initials="YY">Yelena Y.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kelsen</surname><given-names initials="DP">David P.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cho</surname><given-names initials="E">Eunjung</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ladanyi</surname><given-names initials="M">Marc</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tang</surname><given-names initials="L">Laura</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><on-behalf-of>for the Disease Working Group: Memorial Sloan-Kettering Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>McCall</surname><given-names initials="SJ">Shannon J.</given-names></name><xref ref-type="aff" rid="Aff49">49</xref></contrib><on-behalf-of>for the Duke University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="YS">Young S.</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><on-behalf-of>for the Asan Medical Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cheong</surname><given-names initials="JH">Jae-Ho</given-names></name><xref ref-type="aff" rid="Aff50">50</xref></contrib><on-behalf-of>for the Yonsei University College of Medicine</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ajani</surname><given-names initials="J">Jaffer</given-names></name><xref ref-type="aff" rid="Aff51">51</xref></contrib><on-behalf-of>for the MD Anderson Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Camargo</surname><given-names initials="MC">M. Constanza</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><on-behalf-of>for the National Cancer Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Alonso</surname><given-names initials="S">Shelley</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ayala</surname><given-names initials="B">Brenda</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jensen</surname><given-names initials="MA">Mark A.</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pihl</surname><given-names initials="T">Todd</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Raman</surname><given-names initials="R">Rohini</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Walton</surname><given-names initials="J">Jessica</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wan</surname><given-names initials="Y">Yunhu</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><on-behalf-of>for the Data Coordination Center: SRA International</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Demchok</surname><given-names initials="JA">John A.</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Eley</surname><given-names initials="G">Greg</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mills Shaw</surname><given-names initials="KR">Kenna R.</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sheth</surname><given-names initials="M">Margi</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tarnuzzer</surname><given-names initials="R">Roy</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zhining</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="L">Liming</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zenklusen</surname><given-names initials="JC">Jean Claude</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Davidsen</surname><given-names initials="T">Tanja</given-names></name><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hutter</surname><given-names initials="CM">Carolyn M.</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sofia</surname><given-names initials="HJ">Heidi J.</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><on-behalf-of>for the Project Team: National Cancer Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Burton</surname><given-names initials="R">Robert</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chudamani</surname><given-names initials="S">Sudha</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="J">Jia</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><on-behalf-of>for the SAIC-Frederick</on-behalf-of></contrib-group></collab>
          </contrib>
          <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.65499.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 9910</institution-id><institution>Department of Medical Oncology and the Center for Cancer Genome Discovery, </institution><institution>Dana-Farber Cancer Institute, </institution></institution-wrap>Boston, 02215 Massachusetts USA </aff>
          <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.64212.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0463 2320</institution-id><institution>Institute for Systems Biology, </institution></institution-wrap>Seattle, 98109 Washington USA </aff>
          <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution>USC Epigenome Center, University of Southern California, </institution></institution-wrap>Los Angeles, 90033 California USA </aff>
          <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution>Department of Preventive Medicine, </institution><institution>University of Southern California, USC/Norris Comprehensive Cancer Center, </institution></institution-wrap>Los Angeles, 90033 California USA </aff>
          <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Computational Biology Center, Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Epidemiology and Biostatistics, </institution><institution>Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Medicine, </institution><institution>Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.248762.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0702 3000</institution-id><institution>Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada., </institution></institution-wrap>, </aff>
          <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>The Eli and Edythe L. Broad Institute, </institution></institution-wrap>Cambridge, 02142 Massachusetts USA </aff>
          <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Bioinformatics and Computational Biology, </institution><institution>University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
          <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Systems Biology, </institution><institution>University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
          <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Pathology, </institution><institution>University of Texas MD Anderson Cancer Center, </institution></institution-wrap>77030 Texas USA </aff>
          <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Medicine, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, 02215 Massachusetts USA </aff>
          <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Department of Pathology and Laboratory Medicine, </institution><institution>University of North Carolina-Chapel Hill, </institution></institution-wrap>Chapel Hill, Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.412807.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9916</institution-id><institution>Department of Medicine, </institution><institution>Vanderbilt University Medical Center, 2215 Garland Avenue, Nashville, Tennessee 37232, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.413967.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0842 2126</institution-id><institution>Department of Pathology, </institution><institution>University of Ulsan College of Medicine, Asan Medical Center, </institution></institution-wrap>Seoul, 138-736 South Korea </aff>
          <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Sir Peter MacCallum Cancer Department of Oncology, </institution><institution>University of Melbourne, </institution></institution-wrap>East Melbourne, 3002 Australia </aff>
          <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.48336.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8075</institution-id><institution>National Cancer Institute, </institution></institution-wrap>Bethesda, 20892 Maryland USA </aff>
          <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.48336.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8075</institution-id><institution>Division of Cancer Epidemiology and Genetics, </institution><institution>National Cancer Institute, </institution></institution-wrap>Bethesda, 20892 Maryland USA </aff>
          <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.67105.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2164 3847</institution-id><institution>Department of Pathology, </institution><institution>Case Western Reserve University, </institution></institution-wrap>Cleveland, 44106 Ohio USA </aff>
          <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.205975.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0740 6917</institution-id><institution>Department of Biomolecular Engineering and Center for Biomolecular Science and Engineering, </institution><institution>University of California-Santa Cruz, </institution></institution-wrap>Santa Cruz, 95064 California USA </aff>
          <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Division of Gastroenterology, Department of Medicine, </institution><institution>Duke University, </institution></institution-wrap>Durham, 27710 North Carolina USA </aff>
          <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>Department of Thoracic Surgery, </institution><institution>University of Michigan Cancer Center, </institution></institution-wrap>Ann Arbor, 48109 Michigan USA </aff>
          <aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.21925.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9000</institution-id><institution>University of Pittsburgh, </institution></institution-wrap>Pittsburgh, 15213 Pennsylvania USA </aff>
          <aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.40263.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9094</institution-id><institution>Department of Computer Science &amp; Center for Computational Molecular Biology, </institution><institution>Brown University, 115 Waterman Street, Providence, Rhode Island 02912, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution>Department of Pathology, </institution><institution>Brigham and Women’s Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.410914.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 9810</institution-id><institution>National Cancer Center, </institution></institution-wrap>Goyang, 410-769 Republic of Korea </aff>
          <aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.240344.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0392 3476</institution-id><institution>The Research Institute at Nationwide Children's Hospital, </institution></institution-wrap>Columbus, 43205 Ohio USA </aff>
          <aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>The Genome Institute, Washington University, </institution></institution-wrap>St Louis, 63108 Missouri USA </aff>
          <aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.418300.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 1088 774X</institution-id><institution>Greater Poland Cancer Centre, Garbary, 15, 61-866, Poznan, Poland., </institution></institution-wrap>, </aff>
          <aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="GRID">grid.5596.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id><institution>Department of Electrical Engineering-ESAT (STADIUS), </institution><institution>KU Leuven, </institution></institution-wrap>Leuven, Belgium </aff>
          <aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Genomic Medicine, </institution><institution>Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, 77054 Texas USA </aff>
          <aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>The Center for Biomedical Informatics, Harvard Medical School, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Cancer Biology Division, </institution><institution>Johns Hopkins University, </institution></institution-wrap>Baltimore, 21231 Maryland USA </aff>
          <aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, </institution></institution-wrap>San Francisco, 94143-0128 California USA </aff>
          <aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="GRID">grid.450294.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0641 0756</institution-id><institution>International Genomics Consortium, </institution></institution-wrap>Phoenix, 85004 Arizona USA </aff>
          <aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.272799.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8687 5377</institution-id><institution>Buck Institute for Research on Aging, </institution></institution-wrap>Novato, 94945 California USA </aff>
          <aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="GRID">grid.14005.30</institution-id><institution-id institution-id-type="ISNI">0000 0001 0356 9399</institution-id><institution>Chonnam National University Medical School, </institution></institution-wrap>Gwangju, 501-746 Republic of Korea </aff>
          <aff id="Aff39"><label>39</label>City Clinical Oncology Dispensary, Saint Petersburg, 198255 Russia </aff>
          <aff id="Aff40"><label>40</label>Cureline, Inc., South San Francisco, 94080 California USA </aff>
          <aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Departments of Medicine and Genetics, </institution><institution>University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="GRID">grid.414316.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0444 1241</institution-id><institution>Helen F. Graham Cancer Center &amp; Research Institute, Christiana Care Health System, </institution></institution-wrap>Newark, 19713 Delaware USA </aff>
          <aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="GRID">grid.412091.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0669 3109</institution-id><institution>Keimyung University School of Medicine, </institution></institution-wrap>Daegu, 700-712 Republic of Korea </aff>
          <aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="GRID">grid.416721.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0742 7355</institution-id><institution>Ontario Tumour Bank - Hamilton site, St. Joseph’s Healthcare Hamilton, Hamilton, Ontario L8N 3Z5, Canada., </institution></institution-wrap>, </aff>
          <aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="GRID">grid.415354.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0633 727X</institution-id><institution>Ontario Tumour Bank - Kingston site, Kingston General Hospital, Kingston, Ontario K7L 5H6, Canada., </institution></institution-wrap>, </aff>
          <aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="GRID">grid.419890.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0626 690X</institution-id><institution>Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada., </institution></institution-wrap>, </aff>
          <aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="GRID">grid.412588.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 8611 7824</institution-id><institution>Pusan National University Hospital, </institution></institution-wrap>Busan, 602-739 Republic of Korea </aff>
          <aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Pathology, </institution><institution>Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Department of Pathology, </institution><institution>Duke University, </institution></institution-wrap>Durham, 27710 North Carolina USA </aff>
          <aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution>Department of Surgery, </institution><institution>Yonsei University College of Medicine, </institution></institution-wrap>Seoul, 120-752 Republic of Korea </aff>
          <aff id="Aff51"><label>51</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Gastrointestinal Medical Oncology, </institution><institution>University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
          <aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="GRID">grid.421489.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 4656 9526</institution-id><institution>SRA International, </institution></institution-wrap>Fairfax, 22033 Virginia USA </aff>
          <aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="GRID">grid.48336.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8075</institution-id><institution>Center for Biomedical Informatics and Information Technology, National Cancer Institute, </institution></institution-wrap>Rockville, 20850 Maryland USA </aff>
          <aff id="Aff54"><label>54</label><institution-wrap><institution-id institution-id-type="GRID">grid.280128.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2233 9230</institution-id><institution>National Human Genome Research Institute, </institution></institution-wrap>Bethesda, 20892 Maryland USA </aff>
          <aff id="Aff55"><label>55</label><institution-wrap><institution-id institution-id-type="GRID">grid.419407.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 4665 8158</institution-id><institution>SAIC-Frederick, Inc., </institution></institution-wrap>Frederick, 21702 Maryland USA </aff>
        </contrib-group>
        <pub-date pub-type="epub">
          <day>23</day>
          <month>7</month>
          <year>2014</year>
        </pub-date>
        <pub-date pub-type="ppub">
          <year>2014</year>
        </pub-date>
        <volume>513</volume>
        <issue>7517</issue>
        <issue-id pub-id-type="pmc-issue-id">381929</issue-id>
        <fpage>202</fpage>
        <lpage>209</lpage>
        <history>
          <date date-type="received">
            <day>21</day>
            <month>2</month>
            <year>2014</year>
          </date>
          <date date-type="accepted">
            <day>13</day>
            <month>5</month>
            <year>2014</year>
          </date>
        </history>
        <pub-history>
          <event event-type="pmc-release">
            <date>
              <day>23</day>
              <month>07</month>
              <year>2014</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>22</day>
              <month>09</month>
              <year>2014</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-02-08 18:25:11.160">
              <day>08</day>
              <month>02</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-version" specific-use="live">
            <article-id pub-id-type="pmcaiid">4170219</article-id>
            <article-id pub-id-type="doi">10.1038/nature13480</article-id>
            <article-id pub-id-type="manuscript-id">NIHMS627842</article-id>
            <article-version>1</article-version>
            <pub-date>
              <day>23</day>
              <month>07</month>
              <year>2014</year>
            </pub-date>
          </event>
          <event event-type="pmc-version" specific-use="live">
            <article-id pub-id-type="pmcaiid">8171191</article-id>
            <article-id pub-id-type="doi">10.1038/nature13480</article-id>
            <article-version>2</article-version>
            <pub-date>
              <day>23</day>
              <month>07</month>
              <year>2014</year>
            </pub-date>
          </event>
        </pub-history>
        <permissions>
          <copyright-statement>© The Author(s) 2014</copyright-statement>
          <license>
            <ali:license_ref specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/3.0/</ali:license_ref>
            <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported licence. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons licence, users will need to obtain permission from the licence holder to reproduce the material. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/3.0/">http://creativecommons.org/licenses/by-nc-sa/3.0/</ext-link>.</license-p>
          </license>
        </permissions>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41586_2014_Article_BFnature13480.pdf"/>
        <abstract id="Abs1">
          <p>Gastric cancer is a leading cause of cancer deaths, but analysis of its molecular and clinical characteristics has been complicated by histological and aetiological heterogeneity. Here we describe a comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project. We propose a molecular classification dividing gastric cancer into four subtypes: tumours positive for Epstein–Barr virus, which display recurrent <italic toggle="yes">PIK3CA</italic> mutations, extreme DNA hypermethylation, and amplification of <italic toggle="yes">JAK2</italic>, <italic toggle="yes">CD274</italic> (also known as <italic toggle="yes">PD-L1</italic>) and <italic toggle="yes">PDCD1LG2</italic> (also known as <italic toggle="yes">PD-L2</italic>); microsatellite unstable tumours, which show elevated mutation rates, including mutations of genes encoding targetable oncogenic signalling proteins; genomically stable tumours, which are enriched for the diffuse histological variant and mutations of <italic toggle="yes">RHOA</italic> or fusions involving RHO-family GTPase-activating proteins; and tumours with chromosomal instability, which show marked aneuploidy and focal amplification of receptor tyrosine kinases. Identification of these subtypes provides a roadmap for patient stratification and trials of targeted therapies.</p>
          <sec>
            <title>Supplementary information</title>
            <p>The online version of this article (doi:10.1038/nature13480) contains supplementary material, which is available to authorized users.</p>
          </sec>
        </abstract>
        <abstract id="Abs2" abstract-type="web-summary">
          <p>The Cancer Genome Atlas reports on molecular evaluation of 295 primary gastric adenocarcinomas and proposes a new classification of gastric cancers into 4 subtypes, which should help with clinical assessment and trials of targeted therapies.</p>
          <sec>
            <title>Supplementary information</title>
            <p>The online version of this article (doi:10.1038/nature13480) contains supplementary material, which is available to authorized users.</p>
          </sec>
        </abstract>
        <abstract id="Abs3" abstract-type="LongSummary">
          <title>Four classes of gastric adenocarcinoma</title>
          <p>This contribution from The Cancer Genome Atlas (TCGA) project describes the molecular evaluation of 295 primary gastric adenocarcinomas. Based on the results, the authors propose a novel classification separating gastric cancers into four subtypes according to: Epstein–Barr virus positive status, microsatellite instability, chromosomal instability or genomic stability. Given the histologic and etiologic heterogeneity of gastric cancer identification of these subtypes, using a schema that can readily be applied to patient samples should help with patient stratification and trials of targeted therapies.</p>
          <sec>
            <title>Supplementary information</title>
            <p>The online version of this article (doi:10.1038/nature13480) contains supplementary material, which is available to authorized users.</p>
          </sec>
        </abstract>
        <kwd-group kwd-group-type="npg-subject">
          <title>Subject terms</title>
          <kwd>Gastric cancer</kwd>
          <kwd>Cancer genomics</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>issue-copyright-statement</meta-name>
            <meta-value>© Springer Nature Limited 2014</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
    <body>
      <sec id="Sec1">
        <title>Main</title>
        <p>Gastric cancer was the world’s third leading cause of cancer mortality in 2012, responsible for 723,000 deaths<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. The vast majority of gastric cancers are adenocarcinomas, which can be further subdivided into intestinal and diffuse types according to the Lauren classification<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. An alternative system, proposed by the World Health Organization, divides gastric cancer into papillary, tubular, mucinous (colloid) and poorly cohesive carcinomas<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. These classification systems have little clinical utility, making the development of robust classifiers that can guide patient therapy an urgent priority.</p>
        <p>The majority of gastric cancers are associated with infectious agents, including the bacterium <italic toggle="yes">Helicobacter pylori</italic><sup><xref ref-type="bibr" rid="CR4">4</xref></sup> and Epstein–Barr virus (EBV). The distribution of histological subtypes of gastric cancer and the frequencies of <italic toggle="yes">H. pylori</italic> and EBV associated gastric cancer vary across the globe<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. A small minority of gastric cancer cases are associated with germline mutation in E-cadherin (<italic toggle="yes">CDH1</italic>)<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> or mismatch repair genes<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> (Lynch syndrome), whereas sporadic mismatch repair-deficient gastric cancers have epigenetic silencing of <italic toggle="yes">MLH1</italic> in the context of a CpG island methylator phenotype (CIMP)<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Molecular profiling of gastric cancer has been performed using gene expression or DNA sequencing<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>, but has not led to a clear biologic classification scheme. The goals of this study by The Cancer Genome Atlas (TCGA) were to develop a robust molecular classification of gastric cancer and to identify dysregulated pathways and candidate drivers of distinct classes of gastric cancer.</p>
      </sec>
      <sec id="Sec2">
        <title>Sample set and molecular classification</title>
        <p>We obtained gastric adenocarcinoma primary tumour tissue (fresh frozen) from 295 patients not treated with prior chemotherapy or radiotherapy (<xref rid="MOESM36" ref-type="media">Supplementary Methods S1</xref>). All patients provided informed consent, and local Institutional Review Boards approved tissue collection. We used germline DNA from blood or non-malignant gastric mucosa as a reference for detecting somatic alterations. Non-malignant gastric samples were also collected for DNA methylation (<italic toggle="yes">n</italic> = 27) and expression (<italic toggle="yes">n</italic> = 29) analyses. We characterized samples using six molecular platforms (<xref rid="MOESM36" ref-type="media">Supplementary Methods S2–S7</xref>): array-based somatic copy number analysis, whole-exome sequencing, array-based DNA methylation profiling, messenger RNA sequencing, microRNA (miRNA) sequencing and reverse-phase protein array (RPPA), with 77% of the tumours tested by all six platforms. Microsatellite instability (MSI) testing was performed on all tumour DNA, and low-pass (∼6× coverage) whole genome sequencing on 107 tumour/germline pairs.</p>
        <p>To define molecular subgroups of gastric cancer we first performed unsupervised clustering on data from each molecular platform (<xref rid="MOESM36" ref-type="media">Supplementary Methods S2–S7</xref>) and integrated these results, yielding four groups (<xref rid="MOESM36" ref-type="media">Supplementary Methods S10.2</xref>). The first group of tumours was significantly enriched for high EBV burden (<italic toggle="yes">P</italic> = 1.5 × 10<sup>−18</sup>) and showed extensive DNA promoter hypermethylation. A second group was enriched for MSI (<italic toggle="yes">P</italic> = 2.1 × 10<sup>−32</sup>) and showed elevated mutation rates and hypermethylation (including hypermethylation at the <italic toggle="yes">MLH1</italic> promoter). The remaining two groups were distinguished by the presence or absence of extensive somatic copy-number aberrations (SCNAs). As an alternative means to define distinct gastric cancer subgroups, we performed integrative clustering of multiple data types using iCluster<sup><xref ref-type="bibr" rid="CR13">13</xref></sup> (<xref rid="MOESM36" ref-type="media">Supplementary Methods S10.3</xref>). This analysis again indicated that EBV, MSI and the level of SCNAs characterize distinct subgroups (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 10.3</xref>). Based upon these results from analysis of all molecular platforms, we created a decision tree to categorize the 295 gastric cancer samples into four subtypes (<xref rid="Fig1" ref-type="fig">Fig. 1a, b</xref>) using an approach that could more readily be applied to gastric cancer tumours in clinical care. Tumours were first categorized by EBV-positivity (9%), then by MSI-high status, hereafter called MSI (22%), and the remaining tumours were distinguished by degree of aneuploidy into those termed genomically stable (20%) or those exhibiting chromosomal instability (CIN; 50%).<fig id="Fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><title>Molecular subtypes of gastric cancer.</title><p><bold>a</bold>, Gastric cancer cases are divided into subtypes: Epstein–Barr virus (EBV)-positive (red), microsatellite instability (MSI, blue), genomically stable (GS, green) and chromosomal instability (CIN, light purple) and ordered by mutation rate. Clinical (top) and molecular data (top and bottom) from 227 tumours profiled with all six platforms are depicted. <bold>b</bold>, A flowchart outlines how tumours were classified into molecular subtypes. <bold>c</bold>, Differences in clinical and histological characteristics among subtypes with subtypes coloured as in <bold>a</bold>, <bold>b</bold>. The plot of patient age at initial diagnosis shows the median, 25th and 75th percentile values (horizontal bar, bottom and top bounds of the box), and the highest and lowest values within 1.5 times the interquartile range (top and bottom whiskers, respectively). GE, gastroesophageal.</p><p>
<xref rid="MOESM30" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e3348" position="float" orientation="portrait" xlink:href="41586_2014_BFnature13480_Fig1_HTML.jpg"/></fig></p>
        <p>Evaluation of the clinical and histological characteristics of these molecular subtypes revealed enrichment of the diffuse histological subtype in the genomically stable group (40/55 = 73%, <italic toggle="yes">P</italic> = 7.5 × 10<sup>−17</sup>) (<xref rid="Fig1" ref-type="fig">Fig. 1c</xref>), an association not attributable to reduced SCNA detection in low purity tumours (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 2.8</xref>). Each subtype was found throughout the stomach, but CIN tumours showed elevated frequency in the gastroesophageal junction/cardia (65%, <italic toggle="yes">P</italic> = 0.012), whereas most EBV-positive tumours were present in the gastric fundus or body (62%, <italic toggle="yes">P</italic> = 0.03). Genomically stable tumours were diagnosed at an earlier age (median age 59 years, <italic toggle="yes">P</italic> = 4 × 10<sup>−7</sup>), whereas MSI tumours were diagnosed at relatively older ages (median 72 years, <italic toggle="yes">P</italic> = 5 × 10<sup>−5</sup>). MSI patients tended to be female (56%, <italic toggle="yes">P</italic> = 0.001), but most EBV-positive cases were male (81%, <italic toggle="yes">P</italic> = 0.037), as previously reported<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. We did not observe any systematic differences in distribution of subtypes between patients of East Asian and Western origin (<xref rid="MOESM36" ref-type="media">Supplementary Methods S1.8</xref>). Initial outcome data from this cohort did not reveal survival differences between the four subgroups (<xref rid="MOESM36" ref-type="media">Supplementary Information S1.7</xref>)</p>
      </sec>
      <sec id="Sec3">
        <title>EBV-associated DNA hypermethylation</title>
        <p>EBV is found within malignant epithelial cells in 9% of gastric cancers<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. EBV status was determined using mRNA, miRNA, exome and whole-genome sequencing, yielding highly concordant results (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 9.7</xref>). By contrast, we detected only sporadic evidence of <italic toggle="yes">H. pylori</italic>, which may reflect the decline of bacterial counts accompanying the progression from chronic gastritis to subsequent carcinoma, as well as technical loss of luminal bacteria during specimen processing. Unsupervised clustering of CpG methylation performed on unpaired tumour samples revealed that all EBV-positive tumours clustered together and exhibited extreme CIMP, distinct from that in the MSI subtype<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, consistent with prior reports<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> (<xref rid="Fig2" ref-type="fig">Fig. 2a</xref>). Differences between the EBV-CIMP and MSI-associated gastric-CIMP methylation profiles of tumours mirrored differences between these groups in their spectra of mutations (<xref rid="Fig1" ref-type="fig">Fig. 1a</xref>) and gene expression (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 10.6a</xref>). EBV-positive tumours had a higher prevalence of DNA hypermethylation than any cancers reported by TCGA (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 4.6</xref>). All EBV-positive tumours assayed displayed <italic toggle="yes">CDKN2A</italic> (<italic toggle="yes">p16</italic><sup><italic toggle="yes">INK4A</italic></sup>) promoter hypermethylation, but lacked the <italic toggle="yes">MLH1</italic> hypermethylation characteristic of MSI-associated CIMP<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. Genes with promoter hypermethylation most differentially silenced in EBV-positive gastric cancer are shown in <xref rid="MOESM36" ref-type="media">Supplementary Table 4.3</xref>.<fig id="Fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><title>Molecular characteristics of EBV-positive gastric cancers.</title><p><bold>a</bold>, The heatmap represents unsupervised clustering of DNA methylation at CpG sites for 295 tumours into four clusters: EBV-CIMP (<italic toggle="yes">n</italic> = 28), Gastric-CIMP (<italic toggle="yes">n</italic> = 77), cluster 3 (<italic toggle="yes">n</italic> = 73) and cluster 4 (<italic toggle="yes">n</italic> = 117). Profiles for non-malignant gastric mucosa are to the left of the tumours. <bold>b</bold>, The proportion of tumours harbouring <italic toggle="yes">PIK3CA</italic> mutation in the molecular subtypes with mutations at sites noted recurrently in this data set or in the COSMIC database marked separately (top). Locations of <italic toggle="yes">PIK3CA</italic> mutations with the subtype of the sample with each mutation colour-coded (bottom).</p><p>
<xref rid="MOESM31" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e3494" position="float" orientation="portrait" xlink:href="41586_2014_BFnature13480_Fig2_HTML.jpg"/></fig></p>
        <p>We observed strong predilection for <italic toggle="yes">PIK3CA</italic> mutation in EBV-positive gastric cancer as suggested by prior reports<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>, with non-silent <italic toggle="yes">PIK3CA</italic> mutations found in 80% of this subgroup (<italic toggle="yes">P</italic> = 9 × 10<sup>−12</sup>), including 68% of cases with mutations at sites recurrent in this data set or in the COSMIC repository. In contrast, 3 to 42% of tumours in the other subtypes displayed <italic toggle="yes">PIK3CA</italic> mutations. PI(3)-kinase inhibition therefore warrants evaluation in EBV-positive gastric cancer. <italic toggle="yes">PIK3CA</italic> mutations were more dispersed in EBV-positive cancers, but localized in the kinase domain (exon 20) in EBV-negative cancers (<xref rid="Fig2" ref-type="fig">Fig. 2b</xref>). The most highly transcribed EBV viral mRNAs and miRNAs fell within the BamH1A region of the viral genome (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 9.8</xref>) and showed similar expression patterns across tumours, as reported separately<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>.</p>
      </sec>
      <sec id="Sec4">
        <title>Somatic genomic alterations</title>
        <p>To identify recurrently mutated genes, we analysed the 215 tumours with mutation rates below 11.4 mutations per megabase (Mb) (none of which were MSI-positive) separately from the 74 ‘hypermutated’ tumours. Within the hypermutated tumours, we excluded from analysis 11 cases with a distinctly higher mutational burden above 67.7 mutations per Mb (including one tumour with an inactivating <italic toggle="yes">POLE</italic> mutation<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>) (<xref rid="MOESM36" ref-type="media">Supplementary Information S3.2–3.3</xref>), because their large numbers of mutations unduly influence analysis. We used the MutSigCV<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> tool to define recurrent mutations in the 63 remaining hypermutated tumours by first evaluating only base substitution mutations, identifying 10 significantly mutated genes, including <italic toggle="yes">TP53, KRAS, ARID1A, PIK3CA, ERBB3, PTEN</italic> and <italic toggle="yes">HLA-B</italic> (<xref rid="MOESM36" ref-type="media">Supplementary Table 3.5</xref>). We found <italic toggle="yes">ERBB3</italic> mutations in 16 of 63 tumours, with 13 of these tumours having mutations at recurrent sites or sites reported in COSMIC. MutSigCV analysis including insertions/deletions expanded the list of statistically significant mutated genes to 37, including <italic toggle="yes">RNF43, B2M</italic> and <italic toggle="yes">NF1</italic> (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 3.9</xref>). Similarly, HotNet analysis of genes mutated within MSI tumours revealed common alterations in major histocompatibility complex class I genes, including <italic toggle="yes">B2M</italic> and <italic toggle="yes">HLA-B</italic> (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 11.5–11.7</xref>)<italic toggle="yes">. B2M</italic> mutations in colorectal cancers and melanoma result in loss of expression of HLA class 1 complexes<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, suggesting these events benefit hypermutated tumours by reducing antigen presentation to the immune system.</p>
        <p>Through MutSigCV analysis of the 215 non-hypermutated tumours, we identified 25 significantly mutated genes (<xref rid="Fig3" ref-type="fig">Fig. 3</xref>). This gene list again included <italic toggle="yes">TP53, ARID1A, KRAS, PIK3CA</italic> and <italic toggle="yes">RNF43</italic>, but also genes in the β-catenin pathway (<italic toggle="yes">APC</italic> and <italic toggle="yes">CTNNB1</italic>), the TGF-β pathway (<italic toggle="yes">SMAD4</italic> and <italic toggle="yes">SMAD2</italic>), and <italic toggle="yes">RASA1</italic>, a negative regulator of RAS. <italic toggle="yes">ERBB2</italic>, a therapeutic target, was significantly mutated, with 10 of 15 mutations occurring at known hotspots; four cases had the S310F <italic toggle="yes">ERBB2</italic> mutation that is activating and drug-sensitive<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>.<fig id="Fig3" position="float" orientation="portrait"><label>Figure 3</label><caption><title>Significantly mutated genes in non-hypermutated gastric cancer.</title><p><bold>a</bold>, Bars represent somatic mutation rate for the 215 samples with synonymous and non-synonymous mutation rates distinguished by colour. <bold>b</bold>, Significantly mutated genes, identified by MutSigCV, are ranked by the <italic toggle="yes">q</italic> value (right) with samples grouped by subtype. Mutation colour indicates the class of mutation.</p><p>
<xref rid="MOESM32" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e3655" position="float" orientation="portrait" xlink:href="41586_2014_BFnature13480_Fig3_HTML.jpg"/></fig></p>
        <p>In addition to <italic toggle="yes">PIK3CA</italic> mutations, EBV-positive tumours had frequent <italic toggle="yes">ARID1A</italic> (<italic toggle="yes">55%</italic>) and <italic toggle="yes">BCOR</italic> (<italic toggle="yes">23%</italic>) mutations and only rare <italic toggle="yes">TP53</italic> mutations. <italic toggle="yes">BCOR,</italic> encoding an anti-apoptotic protein, is also mutated in leukaemia<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> and medulloblastoma<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Among the CIN tumours, we observed <italic toggle="yes">TP53</italic> mutations in 71% of tumours. <italic toggle="yes">CDH1</italic> somatic mutations were enriched in the genomically stable subtype (37% of cases). <italic toggle="yes">CDH1</italic> germline mutations underlie hereditary diffuse gastric cancer (HDGC). However, germline analysis revealed only two <italic toggle="yes">CDH1</italic> polymorphisms, neither of which is known to be pathogenic. As in the EBV-subtype, inactivating <italic toggle="yes">ARID1A</italic> mutations were prevalent in the genomically stable subtype. We identified mutations of <italic toggle="yes">RHOA</italic> almost exclusively in genomically stable tumours, as discussed below.</p>
        <p>We analysed the patterns of base changes within gastric cancer tumours and noted elevated rates of C to T transitions at CpG dinucleotides. We observed an elevated rate of A to C transversions at the 3′ adenine of AA dinucleotides, especially at AAG trinucleotides, as reported in oesophageal adenocarcinoma<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. The A to C transversions were prominent in CIN, EBV and genomically stable, but as previously observed<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, not in MSI tumours (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 3.10</xref>).</p>
        <p>We identified <italic toggle="yes">RHOA</italic> mutation in 16 cases, and these were enriched in the genomically stable subtype (15% of genomically stable cases, <italic toggle="yes">P</italic> = 0.0039). RHOA, when in the active GTP-bound form, acts through a variety of effectors, including ROCK1, mDIA and Protein Kinase N, to control actin-myosin-dependent cell contractility and cellular motility<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup> and to activate STAT3 to promote tumorigenesis<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. <italic toggle="yes">RHOA</italic> mutations were clustered in two adjacent amino-terminal regions that are predicted to be at the interface of RHOA with ROCK1 and other effectors (<xref rid="Fig4" ref-type="fig">Fig. 4a, b</xref>). <italic toggle="yes">RHOA</italic> mutations were not at sites analogous to oncogenic mutations in RAS-family GTPases. Although one case harboured a codon 17 mutation, we did not identify the dominant-negative G17V mutations noted in T-cell neoplasms<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. Rather, the mutations found in this study may act to modulate signalling downstream of RHOA. Biochemical studies found that the RHOA Y42C mutation attenuated activation of Protein Kinase N, without abrogated activation of mDia or ROCK1<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. RHOA Y42, mutated in five tumours, corresponds to Y40 on HRAS, a residue which when mutated selectively reduces HRAS activation of RAF, but not other RAS effectors<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Given the role of RHOA in cell motility, modulation of RHOA may contribute to the disparate growth patterns and lack of cellular cohesion that are hallmarks of diffuse tumours.<fig id="Fig4" position="float" orientation="portrait"><label>Figure 4</label><caption><title><italic toggle="yes">RHOA</italic> and <italic toggle="yes">ARHGAP6/26</italic> somatic genomic alterations are recurrent in genomically stable gastric cancer.</title><p><bold>a</bold>, Missense mutations in the GTPase <italic toggle="yes">RHOA</italic>, including residues Y42 and D59, linked via hydrogen bond (red arc). <bold>b</bold>, Mutated regions (coloured as in panel <bold>a</bold>) mapped on the structures of RHOA and ROCK1. <bold>c</bold>, A schematic of <italic toggle="yes">CLDN18–ARHGAP26</italic> translocation is shown for the fusion transcript and predicted fusion protein. SH3 denotes SRC homology 3 domain. <bold>d</bold>, The frequency of <italic toggle="yes">RHOA</italic> and <italic toggle="yes">CDH1</italic> mutations, <italic toggle="yes">CLDN18</italic>–<italic toggle="yes">ARHGAP6</italic> or <italic toggle="yes">ARHGAP26</italic> fusions are shown across gastric cancer subtypes. <bold>e</bold>, <italic toggle="yes">RHOA</italic> mutations and <italic toggle="yes">CLDN18</italic>–<italic toggle="yes">ARHGAP6</italic> or <italic toggle="yes">ARHGAP26</italic> fusions are mutually exclusive in genomically stable tumours.</p><p>
<xref rid="MOESM33" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e3839" position="float" orientation="portrait" xlink:href="41586_2014_BFnature13480_Fig4_HTML.jpg"/></fig></p>
        <p>Dysregulated RHO signalling was further implicated by the discovery of recurrent structural genomic alterations. Whole genome sequencing of 107 tumours revealed 5,696 structural rearrangements, including 74 predicted to produce in-frame gene fusions (<xref rid="MOESM36" ref-type="media">Supplementary Information S3.7–3.8</xref>). <italic toggle="yes">De novo</italic> assembly of mRNA sequencing data confirmed 170 structural rearrangements (<xref rid="MOESM36" ref-type="media">Supplementary Information S5.4a</xref>), including two cases with an interchromosomal translocation between <italic toggle="yes">CLDN18</italic> and <italic toggle="yes">ARHGAP26</italic> (<italic toggle="yes">GRAF</italic>). ARHGAP26 is a GTPase-activating protein (GAP) that facilitates conversion of RHO GTPases to the GDP state and has been implicated in enhancing cellular motility<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. CLDN18 is a component of the tight junction adhesion structures<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. RNA sequencing data from tumours without whole genome sequencing identified <italic toggle="yes">CLDN18–ARHGAP26</italic> fusions in 9 additional tumours, with two more cases showing <italic toggle="yes">CLDN18</italic> fusion to the homologous GAP encoded by <italic toggle="yes">ARHGAP6</italic> totalling 13 cases with these rearrangements (<xref rid="MOESM36" ref-type="media">Supplementary Table 5.6</xref>).</p>
        <p>The fusions linked exon 5 of <italic toggle="yes">CLDN18</italic> to exon 2 (<italic toggle="yes">n</italic> = 2) of <italic toggle="yes">ARHGAP6,</italic> to exon 10 (<italic toggle="yes">n</italic> = 1), or to exon 12 (<italic toggle="yes">n</italic> = 10) of <italic toggle="yes">ARHGAP26</italic> (<xref rid="Fig4" ref-type="fig">Fig. 4c</xref>). As these fusions occur downstream of the <italic toggle="yes">CLDN18</italic> exon 5 stop codon, they appeared unlikely to enable translation of fusion proteins. However, mRNA sequencing revealed a mature fusion transcript in which the <italic toggle="yes">ARHGAP26</italic> or <italic toggle="yes">ARHGAP6</italic> splice acceptor activates a cryptic splice site within exon 5 of <italic toggle="yes">CLDN18,</italic> before the stop codon, yielding an in-frame fusion predicted to maintain the transmembrane domains of CLDN18 while fusing a large segment of ARHGAP26 or ARHGAP6 to the cytoplasmic carboxy terminus of CLDN18. These chimaeric proteins retain the carboxy-terminal GAP domain of ARHGAP26/6, potentially affecting ARHGAP’s regulation of RHOA and/or cell motility. Furthermore, these fusions may also disrupt wild-type CLDN18, impacting cellular adhesion. The <italic toggle="yes">CLDN18–ARHGAP</italic> fusions were mutually exclusive with <italic toggle="yes">RHOA</italic> mutations and were enriched in genomically stable tumours (62%, <italic toggle="yes">P</italic> = 10<sup>−3</sup>) (<xref rid="Fig4" ref-type="fig">Fig. 4d</xref>). Within the genomically stable subtype, 30% of cases had either <italic toggle="yes">RHOA</italic> or <italic toggle="yes">CLDN18–ARHGAP</italic> alterations. Evaluation of gene expression status in pathways putatively regulated by RHOA using the Paradigm-Shift algorithm predicted activation of RHOA-driven pathways (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 11.4a–c</xref>), suggesting that these genomic aberrations contribute to the invasive phenotype of diffuse gastric cancer.</p>
        <p>SCNA analysis using GISTIC identified 30 focal amplifications, 45 focal deletions, and chromosome arms subject to frequent alteration (<xref rid="MOESM36" ref-type="media">Supplementary Figs 2.3–2.9</xref>). Focal amplifications targeted oncogenes such as <italic toggle="yes">ERBB2, CCNE1, KRAS, MYC, EGFR, CDK6, GATA4</italic>, <italic toggle="yes">GATA6</italic> and <italic toggle="yes">ZNF217.</italic> Additionally, we saw amplification of the gene that encodes the gastric stem cell marker CD44 and a novel recurrent amplification at 9p24.1 at the locus containing <italic toggle="yes">JAK2</italic>, <italic toggle="yes">CD274</italic> and <italic toggle="yes">PDCD1LG2</italic>. <italic toggle="yes">JAK2</italic> encodes a receptor tyrosine kinase and potential therapeutic target. <italic toggle="yes">CD274</italic> and <italic toggle="yes">PDCD1LG2</italic> encode PD-L1 and PD-L2, immunosuppressant proteins currently being evaluated as targets to augment anti-tumour immune response. Notably, these 9p amplifications were enriched in the EBV subgroup (15% of tumours), consistent with studies showing elevated PD-L1 expression in EBV-positive lymphoid cancers<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>. Evaluation of mRNA revealed elevated expression of <italic toggle="yes">JAK2, PD-L1</italic> and <italic toggle="yes">PD-L2</italic> in amplified cases (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 2.10</xref>). More broadly, PD-L1/2 expression was elevated in EBV-positive tumours, suggesting that PD-L1/2 antagonists and JAK2 inhibitors be tested in this subgroup. Focal deletions were identified at the loci of tumour suppressors such as <italic toggle="yes">PTEN</italic>, <italic toggle="yes">SMAD4, CDKN2A</italic> and <italic toggle="yes">ARID1A</italic>. Additional GISTIC analysis on the four molecular subtypes is detailed in <xref rid="MOESM36" ref-type="media">Supplementary Figs 2.5–2.6</xref>.</p>
      </sec>
      <sec id="Sec5">
        <title>Gene expression and proteomic analysis</title>
        <p>Our analysis of each of the expression platforms revealed four mRNA, five miRNA and three RPPA clusters (<xref rid="MOESM36" ref-type="media">Supplementary Methods S5–S7</xref>). Some expression clusters are similar across platforms (<xref rid="MOESM36" ref-type="media">Supplementary Methods S10</xref>) and/or have correspondence with specific molecular subtypes. For example, mRNA cluster 1, miRNA cluster 4 and RPPA cluster 1 have substantial overlap and are strongly associated with genomically stable tumours, both individually and as a group; the 34 cases with all three assignments were predominantly genomically stable (20/34, <italic toggle="yes">P</italic> = 2 × 10<sup>−8</sup>). Similarly, mRNA cluster 3, miRNA cluster 2 and RPPA cluster 3 are similar and are associated with the MSI subtype as a group (12/22, <italic toggle="yes">P</italic> = 5 × 10<sup>−4</sup>). However, absolute correspondence between expression clusters and molecular subtypes was not always seen. For example, RPPA cluster 3 showed moderate association with both MSI and EBV (<italic toggle="yes">P</italic> = 0.018 and <italic toggle="yes">P</italic> = 0.038, respectively), and miRNA clusters each had similar proportions of CIN (no associations with <italic toggle="yes">P</italic> &lt; 0.05). Overall, the expression data recapitulate features of the molecular classification, pointing to robustness of this taxonomy.</p>
        <p>We analysed mRNA sequence data for alternative splicing events, finding <italic toggle="yes">MET</italic> exon 2 skipping in 82 of 272 (30%) cases, associated with increased MET expression (<italic toggle="yes">P</italic> = 10<sup>−4</sup>). We also found novel variants of <italic toggle="yes">MET</italic> in which exons 18 and/or 19 were skipped (47/272; 17%; <xref rid="MOESM36" ref-type="media">Supplementary Fig. 5.5</xref>). Intriguingly, the exons removed by these alterations encode regions of the kinase domain.</p>
        <p>Through supervised analysis of RPPA data, we observed 45 proteins whose expression or phosphorylation was associated with the four molecular subtypes (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 7.2</xref>). Phosphorylation of EGFR (pY1068) was significantly elevated in the CIN subtype, consistent with amplification of <italic toggle="yes">EGFR</italic> within that subtype. We also found elevated expression of p53, consistent with frequent <italic toggle="yes">TP53</italic> mutation and aneuploidy in the CIN subtype.</p>
      </sec>
      <sec id="Sec6">
        <title>Integrated pathway analysis</title>
        <p>We integrated SCNA and mutation data to characterize genomic alterations in known signalling pathways, including candidate therapeutic targets (<xref rid="Fig5" ref-type="fig">Fig. 5a, b</xref>). We focused on alterations in receptor tyrosine kinases (RTKs) and RAS and PI(3)-kinase signalling. EBV-positive tumours contained <italic toggle="yes">PIK3CA</italic> mutations and recurrent <italic toggle="yes">JAK2</italic> and <italic toggle="yes">ERBB2</italic> amplifications. Although MSI cases generally lacked targetable amplifications, mutations in <italic toggle="yes">PIK3CA</italic>, <italic toggle="yes">ERBB3, ERBB2</italic> and <italic toggle="yes">EGFR</italic> were noted, with many mutations at ‘hotspot’ sites seen in other cancers (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 11.14</xref>). Absent from MSI gastric cancers were <italic toggle="yes">BRAF</italic> V600E mutations, commonly seen in MSI colorectal cancer<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Although the genomically stable subtype exhibited recurrent <italic toggle="yes">RHOA</italic> and <italic toggle="yes">CLDN18</italic> events, few other clear treatment targets were observed. In CIN tumours, we identified genomic amplifications of RTKs, many of which are amenable to blockade by therapeutics in current use or in development. Recurrent amplification of the gene encoding ligand VEGFA was notable given the gastric cancer activity of the VEGFR2 targeting antibody ramucirumab<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Additionally, frequent amplifications of cell cycle mediators (<italic toggle="yes">CCNE1, CCND1</italic> and <italic toggle="yes">CDK6</italic>) suggest the potential for therapeutic inhibition of cyclin-dependent kinases (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 11.15</xref>).<fig id="Fig5" position="float" orientation="portrait"><label>Figure 5</label><caption><title>Integrated molecular description of gastric cancer.</title><p><bold>a</bold>, Mutations, copy-number changes and translocations for select genes are shown across samples organized by molecular subtypes. Mutations that are recurrent in this data set or in the COSMIC repository are distinguished by colour. Alteration frequencies are expressed as a percentage of all cases. <bold>b</bold>, Alterations in RTK/RAS and RTK/PI(3)K signalling pathways across molecular subtypes. Red denotes predicted activation; blue denotes predicted inactivation. <bold>c</bold>, The heatmap shows NCI-PID pathways that are significantly elevated (red) or decreased (blue) in each of the four subtypes as compared with non-malignant gastric mucosa.</p><p>
<xref rid="MOESM34" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e4148" position="float" orientation="portrait" xlink:href="41586_2014_BFnature13480_Fig5_HTML.jpg"/></fig></p>
        <p>We compared expression within each subtype to that of the other subtypes, and to non-malignant gastric tissue (<italic toggle="yes">n</italic> = 29) (<xref rid="MOESM36" ref-type="media">Supplementary Fig. 11.2</xref>). We computed an aggregate score for each pathway of the NCI pathway interaction database<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> and determined statistical significance by comparison with randomly generated pathways (<xref rid="MOESM36" ref-type="media">Supplementary Methods S11</xref>). Hierarchical clustering of samples and pathways (<xref rid="Fig5" ref-type="fig">Fig. 5c</xref>) revealed several notable patterns, including elevated expression of mitotic network components such as AURKA/B and E2F, targets of MYC activation, FOXM1 and PLK1 signalling and DNA damage response pathways across all subtypes, but to a lesser degree in genomically stable tumours. In contrast, the genomically stable subtype exhibited elevated expression of cell adhesion pathways, including the B1/B3 integrins, syndecan-1 mediated signalling, and angiogenesis-related pathways. These results suggest additional candidate therapeutic targets, including the aurora kinases (AURKA/B) and Polo-like (PLK) family members. The strength of IL-12 mediated signalling signatures in EBV-positive tumours suggests a robust immune cell presence. When coupled with evidence of PD-L1/2 overexpression, this finding adds rationale for testing immune checkpoint inhibitors in EBV-positive gastric cancer.</p>
      </sec>
      <sec id="Sec7">
        <title>Discussion</title>
        <p>Through this study of the molecular and genomic basis of gastric cancer, we describe a molecular classification (<xref rid="Fig6" ref-type="fig">Fig. 6</xref>) that defines four major genomic subtypes of gastric cancer: EBV-infected tumours; MSI tumours; genomically stable tumours; and chromosomally unstable tumours. This classification may serve as a valuable adjunct to histopathology. Importantly, these molecular subtypes showed distinct salient genomic features, providing a guide to targeted agents that should be evaluated in clinical trials for distinct populations of gastric cancer patients. Through existing testing for MSI and EBV and the use of emerging genomic assays that query focused gene sets for mutations and amplifications, the classification system developed through this study can be applied to new gastric cancer cases. We hope these results will facilitate the development of clinical trials to explore therapies in defined sets of patients, ultimately improving survival from this deadly disease.<fig id="Fig6" position="float" orientation="portrait"><label>Figure 6</label><caption><title>Key features of gastric cancer subtypes.</title><p>This schematic lists some of the salient features associated with each of the four molecular subtypes of gastric cancer. Distribution of molecular subtypes in tumours obtained from distinct regions of the stomach is represented by inset charts.</p><p>
<xref rid="MOESM35" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e4190" position="float" orientation="portrait" xlink:href="41586_2014_BFnature13480_Fig6_HTML.jpg"/></fig></p>
      </sec>
      <sec id="Sec8">
        <title>Methods Summary</title>
        <p>Fresh frozen gastric adenocarcinoma and matched germline DNA samples were obtained from 295 patients under IRB approved protocols. Genomic material and (when available) protein were subjected to single nucleotide polymorphism array somatic copy-number analysis, whole-exome sequencing, mRNA sequencing, miRNA sequencing, array-based DNA methylation profiling and reverse-phase protein arrays. A subset of samples was subjected to whole-genome sequencing. Initial analysis centred on the development of a classification scheme for gastric cancer. Subsequent analysis identified key features from each of the genomic/molecular platforms, looking both for features found across gastric cancer and those characteristic of individual gastric cancer subtypes. Primary and processed data are deposited at the Data Coordinating Center (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp">https://tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp</ext-link>); primary sequence files are deposited in CGHub (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://cghub.ucsc.edu/">https://cghub.ucsc.edu/</ext-link>). Sample lists, and supporting data can be found at (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/docs/publications/stad_2014/">https://tcga-data.nci.nih.gov/docs/publications/stad_2014/</ext-link>).</p>
      </sec>
      <sec sec-type="supplementary-material">
        <title>Supplementary information</title>
        <sec id="Sec9">
          <p>
<supplementary-material content-type="local-data" id="MOESM36" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41586_2014_BFnature13480_MOESM36_ESM.pdf" position="float" orientation="portrait"><caption><title>Supplementary Information</title><p>This file contains Supplementary Information – see contents pages 1-4 for full details. (PDF 9697 kb)</p></caption></media></supplementary-material>
</p>
        </sec>
      </sec>
    </body>
    <back>
      <app-group>
        <app id="App1">
          <sec id="Sec10">
            <title>PowerPoint slides</title>
            <p>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2014_BFnature13480_MOESM30_ESM.ppt" id="MOESM30" orientation="portrait"><caption><p>PowerPoint slide for Fig. 1</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2014_BFnature13480_MOESM31_ESM.ppt" id="MOESM31" orientation="portrait"><caption><p>PowerPoint slide for Fig. 2</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2014_BFnature13480_MOESM32_ESM.ppt" id="MOESM32" orientation="portrait"><caption><p>PowerPoint slide for Fig. 3</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2014_BFnature13480_MOESM33_ESM.ppt" id="MOESM33" orientation="portrait"><caption><p>PowerPoint slide for Fig. 4</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2014_BFnature13480_MOESM34_ESM.ppt" id="MOESM34" orientation="portrait"><caption><p>PowerPoint slide for Fig. 5</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2014_BFnature13480_MOESM35_ESM.ppt" id="MOESM35" orientation="portrait"><caption><p>PowerPoint slide for Fig. 6</p></caption></media>
</p>
          </sec>
        </app>
      </app-group>
      <fn-group>
        <fn>
          <p>The primary and processed data used to generate the analyses presented here can be downloaded from The Cancer Genome Atlas at (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp">https://tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp</ext-link>). All of the primary sequence files are deposited in CGHub and all other data are deposited at the Data Coordinating Center (DCC) for public access (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cancergenome.nih.gov/">http://cancergenome.nih.gov/</ext-link>) and (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://cghub.ucsc.edu/">https://cghub.ucsc.edu/</ext-link>). Additional sample data and supporting data are available from (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/docs/publications/stad_2014/">https://tcga-data.nci.nih.gov/docs/publications/stad_2014/</ext-link>).</p>
        </fn>
        <fn>
          <p>
            <bold>Change history</bold>
          </p>
          <p>9/10/2014</p>
          <p>A minor correction was made to the author list</p>
        </fn>
      </fn-group>
      <ack>
        <title>Acknowledgements</title>
        <p>We are grateful to all the patients and families who contributed to this study and to C. Gunter and J. Weinstein for scientific editing, to M. Sheth for administrative support and to L. Omberg for support with the Sage Bionetworks Synapse platform. This work was supported by the Intramural Research Program and the following grants from the United States National Institutes of Health: 5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273 and P30CA16672.</p>
      </ack>
      <notes notes-type="author-contribution">
        <title>Author Contributions</title>
        <p>The Cancer Genome Atlas Research Network contributed collectively to this study. Biospecimens were provided by the tissue source sites and processed by the Biospecimen Core Resource. Data generation and analyses were performed by the genome-sequencing centres, cancer genome-characterization centres and genome data analysis centres. All data were released through the Data Coordinating Center. The NCI and NHGRI project teams coordinated project activities. The following TCGA investigators of the Stomach Analysis Working Group contributed substantially to the analysis and writing of this manuscript. Project leaders, A. J. Bass, P. W. Laird, I. Shmulevich; data coordinator, V. Thorsson; analysis coordinators, V. Thorsson, N. Schultz; manuscript coordinator, M. Sheth; graphics coordinator, T. Hinoue; DNA sequence analysis, A. Taylor-Weiner, A. Pantazi, C. Sougnez, K. Kasaian; mRNA analysis, R. Bowlby, A. J. Mungall; miRNA analysis, A. Chu, A. Gordon Robertson, D. Yang; DNA methylation analysis, T. Hinoue, H. Shen, P. W. Laird; copy number analysis, A. Cherniack; protein analysis, J.-S. Lee, R. Akbani; pathway/integrated analysis, N. Weinhold, S. Reynolds, C. Curtis, R. Shen, S. Ng, B. Raphael, H.-T. Wu, Y. Liu, V. Thorsson, N. Schultz; pathology expertise and clinical data, A. Boussioutas, B. G. Schneider, J. Kim, J. E. Willis, M. L. Gulley, K. Garman, M. Blanca Piazuelo, V. Thorsson, K. M. Leraas, T. Lichtenberg, J. A. Demchok, A. J. Bass; microbiome analysis, C. S. Rabkin, M. L. Gulley, R. Bowlby, A. J. Mungall, A. Chu and C. Pedamallu.</p>
      </notes>
      <notes notes-type="COI-statement">
        <title>Competing interests</title>
        <p>The author declare no competing financial interests.</p>
      </notes>
      <ref-list id="Bib1">
        <title>References</title>
        <ref id="CR1">
          <label>1</label>
          <mixed-citation publication-type="other">Ferlay, J. et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide. IARC CancerBase <bold>11</bold>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://globocan.iarc.fr">http://globocan.iarc.fr</ext-link>, accessed on January 15, 2014 (2013)</mixed-citation>
        </ref>
        <ref id="CR2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Laurén</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma</article-title>
            <source>Acta Pathol., Microbiol. Scand.</source>
            <year>1965</year>
            <volume>64</volume>
            <fpage>31</fpage>
            <lpage>49</lpage>
            <pub-id pub-id-type="doi">10.1111/apm.1965.64.1.31</pub-id>
            <pub-id pub-id-type="pmid">14320675</pub-id>
          </element-citation>
        </ref>
        <ref id="CR3">
          <label>3</label>
          <mixed-citation publication-type="other"><italic toggle="yes">WHO Classification of Tumours of the Digestive System</italic> 4th edn. (International Agency for Research on Cancer, 2010)</mixed-citation>
        </ref>
        <ref id="CR4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Uemura</surname>
                <given-names>N</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title><italic toggle="yes">Helicobacter pylori</italic> infection and the development of gastric cancer</article-title>
            <source>N. Engl. J. Med.</source>
            <year>2001</year>
            <volume>345</volume>
            <fpage>784</fpage>
            <lpage>789</lpage>
            <pub-id pub-id-type="doi">10.1056/NEJMoa001999</pub-id>
            <pub-id pub-id-type="pmid">11556297</pub-id>
          </element-citation>
        </ref>
        <ref id="CR5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bertuccio</surname>
                <given-names>P</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Recent patterns in gastric cancer: a global overview</article-title>
            <source>International J. Cancer</source>
            <year>2009</year>
            <volume>125</volume>
            <fpage>666</fpage>
            <lpage>673</lpage>
            <pub-id pub-id-type="doi">10.1002/ijc.24290</pub-id>
            <pub-id pub-id-type="pmid">19382179</pub-id>
          </element-citation>
        </ref>
        <ref id="CR6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Richards</surname>
                <given-names>FM</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Germline E-cadherin gene (<italic toggle="yes">CDH1</italic>) mutations predispose to familial gastric cancer and colorectal cancer</article-title>
            <source>Hum. Mol. Genet.</source>
            <year>1999</year>
            <volume>8</volume>
            <fpage>607</fpage>
            <lpage>610</lpage>
            <pub-id pub-id-type="doi">10.1093/hmg/8.4.607</pub-id>
            <pub-id pub-id-type="pmid">10072428</pub-id>
          </element-citation>
        </ref>
        <ref id="CR7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Keller</surname>
                <given-names>G</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Analysis for microsatellite instability and mutations of the DNA mismatch repair gene <italic toggle="yes">hMLH1</italic> in familial gastric cancer</article-title>
            <source>International J Cancer</source>
            <year>1996</year>
            <volume>68</volume>
            <fpage>571</fpage>
            <lpage>576</lpage>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1097-0215(19961127)68:5&amp;#x0003c;571::AID-IJC3&amp;#x0003e;3.0.CO;2-W</pub-id>
            <pub-id pub-id-type="pmid">8938136</pub-id>
          </element-citation>
        </ref>
        <ref id="CR8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Toyota</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype</article-title>
            <source>Cancer Res.</source>
            <year>1999</year>
            <volume>59</volume>
            <fpage>5438</fpage>
            <lpage>5442</lpage>
            <pub-id pub-id-type="pmid">10554013</pub-id>
          </element-citation>
        </ref>
        <ref id="CR9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Tan</surname>
                <given-names>IB</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy</article-title>
            <source>Gastroenterology</source>
            <year>2011</year>
            <volume>141</volume>
            <fpage>476</fpage>
            <lpage>485</lpage>
            <pub-id pub-id-type="doi">10.1053/j.gastro.2011.04.042</pub-id>
            <pub-id pub-id-type="pmid">21684283</pub-id>
            <pub-id pub-id-type="pmcid">PMC3152688</pub-id>
          </element-citation>
        </ref>
        <ref id="CR10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lei</surname>
                <given-names>Z</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil</article-title>
            <source>Gastroenterology</source>
            <year>2013</year>
            <volume>145</volume>
            <fpage>554</fpage>
            <lpage>565</lpage>
            <pub-id pub-id-type="doi">10.1053/j.gastro.2013.05.010</pub-id>
            <pub-id pub-id-type="pmid">23684942</pub-id>
          </element-citation>
        </ref>
        <ref id="CR11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Boussioutas</surname>
                <given-names>A</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer</article-title>
            <source>Cancer Res.</source>
            <year>2003</year>
            <volume>63</volume>
            <fpage>2569</fpage>
            <lpage>2577</lpage>
            <pub-id pub-id-type="pmid">12750281</pub-id>
          </element-citation>
        </ref>
        <ref id="CR12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Exome sequencing identifies frequent mutation of <italic toggle="yes">ARID1A</italic> in molecular subtypes of gastric cancer</article-title>
            <source>Nature Genet.</source>
            <year>2011</year>
            <volume>43</volume>
            <fpage>1219</fpage>
            <lpage>1223</lpage>
            <pub-id pub-id-type="doi">10.1038/ng.982</pub-id>
            <pub-id pub-id-type="pmid">22037554</pub-id>
          </element-citation>
        </ref>
        <ref id="CR13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shen</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Olshen</surname>
                <given-names>AB</given-names>
              </name>
              <name name-style="western">
                <surname>Ladanyi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis</article-title>
            <source>Bioinformatics</source>
            <year>2009</year>
            <volume>25</volume>
            <fpage>2906</fpage>
            <lpage>2912</lpage>
            <pub-id pub-id-type="doi">10.1093/bioinformatics/btp543</pub-id>
            <pub-id pub-id-type="pmid">19759197</pub-id>
            <pub-id pub-id-type="pmcid">PMC2800366</pub-id>
          </element-citation>
        </ref>
        <ref id="CR14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Murphy</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Pfeiffer</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Camargo</surname>
                <given-names>MC</given-names>
              </name>
              <name name-style="western">
                <surname>Rabkin</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location</article-title>
            <source>Gastroenterology</source>
            <year>2009</year>
            <volume>137</volume>
            <fpage>824</fpage>
            <lpage>833</lpage>
            <pub-id pub-id-type="doi">10.1053/j.gastro.2009.05.001</pub-id>
            <pub-id pub-id-type="pmid">19445939</pub-id>
            <pub-id pub-id-type="pmcid">PMC3513767</pub-id>
          </element-citation>
        </ref>
        <ref id="CR15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Matsusaka</surname>
                <given-names>K</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Classification of Epstein–Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes</article-title>
            <source>Cancer Res.</source>
            <year>2011</year>
            <volume>71</volume>
            <fpage>7187</fpage>
            <lpage>7197</lpage>
            <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-1349</pub-id>
            <pub-id pub-id-type="pmid">21990320</pub-id>
          </element-citation>
        </ref>
        <ref id="CR16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Geddert</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Zur Hausen</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Gabbert</surname>
                <given-names>HE</given-names>
              </name>
              <name name-style="western">
                <surname>Sarbia</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1</article-title>
            <source>Anal. Cell. Pathol.</source>
            <year>2010</year>
            <volume>33</volume>
            <fpage>143</fpage>
            <lpage>149</lpage>
            <pub-id pub-id-type="doi">10.1155/2010/453764</pub-id>
            <pub-id pub-id-type="pmcid">PMC4605817</pub-id>
            <pub-id pub-id-type="pmid">20978327</pub-id>
          </element-citation>
        </ref>
        <ref id="CR17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma</article-title>
            <source>PLoS ONE</source>
            <year>2012</year>
            <volume>7</volume>
            <fpage>e38892</fpage>
            <pub-id pub-id-type="doi">10.1371/journal.pone.0038892</pub-id>
            <pub-id pub-id-type="pmid">22723903</pub-id>
            <pub-id pub-id-type="pmcid">PMC3377730</pub-id>
          </element-citation>
        </ref>
        <ref id="CR18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sukawa</surname>
                <given-names>Y</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer</article-title>
            <source>World J. Gastroenterology</source>
            <year>2012</year>
            <volume>18</volume>
            <fpage>6577</fpage>
            <lpage>6586</lpage>
            <pub-id pub-id-type="doi">10.3748/wjg.v18.i45.6577</pub-id>
            <pub-id pub-id-type="pmcid">PMC3516204</pub-id>
            <pub-id pub-id-type="pmid">23236232</pub-id>
          </element-citation>
        </ref>
        <ref id="CR19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Strong</surname>
                <given-names>MJ</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy</article-title>
            <source>PLoS Pathog.</source>
            <year>2013</year>
            <volume>9</volume>
            <fpage>e1003341</fpage>
            <pub-id pub-id-type="doi">10.1371/journal.ppat.1003341</pub-id>
            <pub-id pub-id-type="pmid">23671415</pub-id>
            <pub-id pub-id-type="pmcid">PMC3649992</pub-id>
          </element-citation>
        </ref>
        <ref id="CR20">
          <label>20</label>
          <mixed-citation publication-type="other">The Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. <italic toggle="yes">Nature</italic><bold>487</bold>, 330–337 (2012)<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature11252</pub-id><pub-id pub-id-type="pmcid">PMC3401966</pub-id><pub-id pub-id-type="pmid">22810696</pub-id></mixed-citation>
        </ref>
        <ref id="CR21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Levine</surname>
                <given-names>Douglas A.</given-names>
              </name>
            </person-group>
            <article-title>Integrated genomic characterization of endometrial carcinoma</article-title>
            <source>Nature</source>
            <year>2013</year>
            <volume>497</volume>
            <issue>7447</issue>
            <fpage>67</fpage>
            <lpage>73</lpage>
            <pub-id pub-id-type="doi">10.1038/nature12113</pub-id>
            <pub-id pub-id-type="pmid">23636398</pub-id>
            <pub-id pub-id-type="pmcid">PMC3704730</pub-id>
          </element-citation>
        </ref>
        <ref id="CR22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lawrence</surname>
                <given-names>MS</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Mutational heterogeneity in cancer and the search for new cancer-associated genes</article-title>
            <source>Nature</source>
            <year>2013</year>
            <volume>499</volume>
            <fpage>214</fpage>
            <lpage>218</lpage>
            <pub-id pub-id-type="doi">10.1038/nature12213</pub-id>
            <pub-id pub-id-type="pmid">23770567</pub-id>
            <pub-id pub-id-type="pmcid">PMC3919509</pub-id>
          </element-citation>
        </ref>
        <ref id="CR23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bernal</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Ruiz-Cabello</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Concha</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Paschen</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Garrido</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes</article-title>
            <source>Cancer Immunol. Immunother.</source>
            <year>2012</year>
            <volume>61</volume>
            <fpage>1359</fpage>
            <lpage>1371</lpage>
            <pub-id pub-id-type="doi">10.1007/s00262-012-1321-6</pub-id>
            <pub-id pub-id-type="pmid">22833104</pub-id>
            <pub-id pub-id-type="pmcid">PMC11029609</pub-id>
          </element-citation>
        </ref>
        <ref id="CR24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Greulich</surname>
                <given-names>H</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of <italic toggle="yes">ERBB2</italic></article-title>
            <source>Proc. Natl Acad. Sci. USA</source>
            <year>2012</year>
            <volume>109</volume>
            <fpage>14476</fpage>
            <lpage>14481</lpage>
            <pub-id pub-id-type="doi">10.1073/pnas.1203201109</pub-id>
            <pub-id pub-id-type="pmid">22908275</pub-id>
            <pub-id pub-id-type="pmcid">PMC3437859</pub-id>
          </element-citation>
        </ref>
        <ref id="CR25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Grossmann</surname>
                <given-names>V</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Whole-exome sequencing identifies somatic mutations of <italic toggle="yes">BCOR</italic> in acute myeloid leukemia with normal karyotype</article-title>
            <source>Blood</source>
            <year>2011</year>
            <volume>118</volume>
            <fpage>6153</fpage>
            <lpage>6163</lpage>
            <pub-id pub-id-type="doi">10.1182/blood-2011-07-365320</pub-id>
            <pub-id pub-id-type="pmid">22012066</pub-id>
          </element-citation>
        </ref>
        <ref id="CR26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Pugh</surname>
                <given-names>TJ</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations</article-title>
            <source>Nature</source>
            <year>2012</year>
            <volume>488</volume>
            <fpage>106</fpage>
            <lpage>110</lpage>
            <pub-id pub-id-type="doi">10.1038/nature11329</pub-id>
            <pub-id pub-id-type="pmid">22820256</pub-id>
            <pub-id pub-id-type="pmcid">PMC3413789</pub-id>
          </element-citation>
        </ref>
        <ref id="CR27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Dulak</surname>
                <given-names>AM</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity</article-title>
            <source>Nature Genet.</source>
            <year>2013</year>
            <volume>45</volume>
            <fpage>478</fpage>
            <lpage>486</lpage>
            <pub-id pub-id-type="doi">10.1038/ng.2591</pub-id>
            <pub-id pub-id-type="pmid">23525077</pub-id>
            <pub-id pub-id-type="pmcid">PMC3678719</pub-id>
          </element-citation>
        </ref>
        <ref id="CR28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ridley</surname>
                <given-names>AJ</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Cell migration: integrating signals from front to back</article-title>
            <source>Science</source>
            <year>2003</year>
            <volume>302</volume>
            <fpage>1704</fpage>
            <lpage>1709</lpage>
            <pub-id pub-id-type="doi">10.1126/science.1092053</pub-id>
            <pub-id pub-id-type="pmid">14657486</pub-id>
          </element-citation>
        </ref>
        <ref id="CR29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Thumkeo</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Watanabe</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Narumiya</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Physiological roles of Rho and Rho effectors in mammals</article-title>
            <source>Eur. J. Cell Biol.</source>
            <year>2013</year>
            <volume>92</volume>
            <fpage>303</fpage>
            <lpage>315</lpage>
            <pub-id pub-id-type="doi">10.1016/j.ejcb.2013.09.002</pub-id>
            <pub-id pub-id-type="pmid">24183240</pub-id>
          </element-citation>
        </ref>
        <ref id="CR30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Aznar</surname>
                <given-names>S</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation</article-title>
            <source>Mol. Biol. Cell</source>
            <year>2001</year>
            <volume>12</volume>
            <fpage>3282</fpage>
            <lpage>3294</lpage>
            <pub-id pub-id-type="doi">10.1091/mbc.12.10.3282</pub-id>
            <pub-id pub-id-type="pmid">11598209</pub-id>
            <pub-id pub-id-type="pmcid">PMC60173</pub-id>
          </element-citation>
        </ref>
        <ref id="CR31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Jove</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The STATs of cancer–new molecular targets come of age</article-title>
            <source>Nature Rev. Cancer</source>
            <year>2004</year>
            <volume>4</volume>
            <fpage>97</fpage>
            <lpage>105</lpage>
            <pub-id pub-id-type="doi">10.1038/nrc1275</pub-id>
            <pub-id pub-id-type="pmid">14964307</pub-id>
          </element-citation>
        </ref>
        <ref id="CR32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Palomero</surname>
                <given-names>T</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Recurrent mutations in epigenetic regulators, <italic toggle="yes">RHOA</italic> and <italic toggle="yes">FYN</italic> kinase in peripheral T cell lymphomas</article-title>
            <source>Nature Genet.</source>
            <year>2014</year>
            <volume>46</volume>
            <fpage>166</fpage>
            <lpage>170</lpage>
            <pub-id pub-id-type="doi">10.1038/ng.2873</pub-id>
            <pub-id pub-id-type="pmid">24413734</pub-id>
            <pub-id pub-id-type="pmcid">PMC3963408</pub-id>
          </element-citation>
        </ref>
        <ref id="CR33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sakata-Yanagimoto</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Somatic <italic toggle="yes">RHOA</italic> mutation in angioimmunoblastic T cell lymphoma</article-title>
            <source>Nature Genet.</source>
            <year>2014</year>
            <volume>46</volume>
            <fpage>171</fpage>
            <lpage>175</lpage>
            <pub-id pub-id-type="doi">10.1038/ng.2872</pub-id>
            <pub-id pub-id-type="pmid">24413737</pub-id>
          </element-citation>
        </ref>
        <ref id="CR34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Doherty</surname>
                <given-names>GJ</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading</article-title>
            <source>Mol. Biol. Cell</source>
            <year>2011</year>
            <volume>22</volume>
            <fpage>4380</fpage>
            <lpage>4389</lpage>
            <pub-id pub-id-type="doi">10.1091/mbc.e10-12-0936</pub-id>
            <pub-id pub-id-type="pmid">21965292</pub-id>
            <pub-id pub-id-type="pmcid">PMC3216663</pub-id>
          </element-citation>
        </ref>
        <ref id="CR35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Joneson</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>White</surname>
                <given-names>MA</given-names>
              </name>
              <name name-style="western">
                <surname>Wigler</surname>
                <given-names>MH</given-names>
              </name>
              <name name-style="western">
                <surname>Bar-Sagi</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS</article-title>
            <source>Science</source>
            <year>1996</year>
            <volume>271</volume>
            <fpage>810</fpage>
            <lpage>812</lpage>
            <pub-id pub-id-type="doi">10.1126/science.271.5250.810</pub-id>
            <pub-id pub-id-type="pmid">8628998</pub-id>
          </element-citation>
        </ref>
        <ref id="CR36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Türeci</surname>
                <given-names>O</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals</article-title>
            <source>Gene</source>
            <year>2011</year>
            <volume>481</volume>
            <fpage>83</fpage>
            <lpage>92</lpage>
            <pub-id pub-id-type="doi">10.1016/j.gene.2011.04.007</pub-id>
            <pub-id pub-id-type="pmid">21571049</pub-id>
          </element-citation>
        </ref>
        <ref id="CR37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>BJ</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies</article-title>
            <source>Clinical Cancer Res</source>
            <year>2013</year>
            <volume>19</volume>
            <fpage>3462</fpage>
            <lpage>3473</lpage>
            <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-13-0855</pub-id>
            <pub-id pub-id-type="pmid">23674495</pub-id>
            <pub-id pub-id-type="pmcid">PMC4102335</pub-id>
          </element-citation>
        </ref>
        <ref id="CR38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Green</surname>
                <given-names>MR</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy</article-title>
            <source>Clinical Cancer Res</source>
            <year>2012</year>
            <volume>18</volume>
            <fpage>1611</fpage>
            <lpage>1618</lpage>
            <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-1942</pub-id>
            <pub-id pub-id-type="pmid">22271878</pub-id>
            <pub-id pub-id-type="pmcid">PMC3321508</pub-id>
          </element-citation>
        </ref>
        <ref id="CR39">
          <label>39</label>
          <mixed-citation publication-type="other">The Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. <italic toggle="yes">Nature</italic><bold>487</bold>, 330–337 (2012)<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature11252</pub-id><pub-id pub-id-type="pmcid">PMC3401966</pub-id><pub-id pub-id-type="pmid">22810696</pub-id></mixed-citation>
        </ref>
        <ref id="CR40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Fuchs</surname>
                <given-names>CS</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial</article-title>
            <source>Lancet</source>
            <year>2014</year>
            <volume>383</volume>
            <fpage>31</fpage>
            <lpage>39</lpage>
            <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61719-5</pub-id>
            <pub-id pub-id-type="pmid">24094768</pub-id>
          </element-citation>
        </ref>
        <ref id="CR41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Schaefer</surname>
                <given-names>CF</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>PID: the pathway interaction database</article-title>
            <source>Nucleic Acids Res.</source>
            <year>2009</year>
            <volume>37</volume>
            <fpage>D674</fpage>
            <lpage>D679</lpage>
            <pub-id pub-id-type="doi">10.1093/nar/gkn653</pub-id>
            <pub-id pub-id-type="pmid">18832364</pub-id>
            <pub-id pub-id-type="pmcid">PMC2686461</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </article>
</pmc-articleset>
